Adverse Effect. The parties shall establish and implement a procedure for the mutual exchange of adverse effects reports and safety information concerning the Licensed Product to compliance with applicable law and regulatory guidelines. The detail of the operating procedure shall be separately agreed by the parties.
Appears in 4 contracts
Sources: License Agreement (Oncotelic Therapeutics, Inc.), License Agreement (Adhera Therapeutics, Inc.), License Agreement (Pharmasset Inc)